Spreadbury C, Holden D, Aufauvre-Brown A, Bainbridge B, Cohen J
Department of Infectious Diseases and Bacteriology, Royal Postgraduate Medical School, Hammersmith Hospital, United Kingdom.
J Clin Microbiol. 1993 Mar;31(3):615-21. doi: 10.1128/jcm.31.3.615-621.1993.
Aspergillus fumigatus is an opportunistic nosocomial pathogen causing an often fatal pneumonia, invasive aspergillosis (IA), in immunosuppressed patients. Oligonucleotide primers were used to amplify a 401-bp fragment spanning the 26S/intergenic spacer region of the rDNA complex of A. fumigatus by the polymerase chain reaction (PCR). The primers were highly sensitive and specific: as little as 1 pg of A. fumigatus genomic DNA could be detected, and the primers only amplified DNA from A. fumigatus and not any other fungal, bacterial, viral, or human DNA tested. Using the PCR, we were able to detect A. fumigatus DNA in lung homogenates from immunosuppressed mice experimentally infected with A. fumigatus but not from immunosuppressed uninfected controls. There was 93% correlation between the culture results and the PCR results. In a retrospective clinical study, the sensitivity of the PCR for the detection of A. fumigatus in clinical samples was confirmed by positive amplification in three of three culture-positive respiratory samples from confirmed cases of IA. Because isolation of Aspergillus spp. may reflect contamination and colonization without infection, the feasibility of using the PCR was evaluated by analyzing culture-negative samples from both immunosuppressed patients at high risk for IA and immunocompetent patients with other lung infections. Only 2 of 10 patients were culture negative and PCR positive in the high-risk group, and 2 of 7 patients were culture negative and PCR positive in the immunocompetent group. The results indicate that PCR detection might be a valuable adjunct to current laboratory methods to diagnose IA.
烟曲霉是一种机会性医院病原体,可在免疫抑制患者中引发通常致命的肺炎,即侵袭性曲霉病(IA)。使用寡核苷酸引物通过聚合酶链反应(PCR)扩增跨越烟曲霉rDNA复合体26S/基因间隔区的401bp片段。这些引物具有高度敏感性和特异性:可检测到低至1pg的烟曲霉基因组DNA,且引物仅扩增烟曲霉的DNA,而不扩增所测试的任何其他真菌、细菌、病毒或人类DNA。通过PCR,我们能够在实验性感染烟曲霉的免疫抑制小鼠的肺匀浆中检测到烟曲霉DNA,但在未感染的免疫抑制对照小鼠中未检测到。培养结果与PCR结果之间的相关性为93%。在一项回顾性临床研究中,来自确诊IA病例的三个培养阳性呼吸道样本均通过阳性扩增证实了PCR检测烟曲霉临床样本的敏感性。由于曲霉菌属的分离可能反映污染和定植而非感染,因此通过分析来自IA高危免疫抑制患者和患有其他肺部感染的免疫功能正常患者的培养阴性样本,评估了使用PCR的可行性。在高危组中,10名患者中只有2名培养阴性且PCR阳性,在免疫功能正常组中,7名患者中有2名培养阴性且PCR阳性。结果表明,PCR检测可能是当前诊断IA实验室方法的一种有价值的辅助手段。